Twist1 promotes epithelial-mesenchymal transition, invasion, metastasis, and chemotherapy resistance in cancer cells and thus is a potential target for cancer therapy (Kang and Massague, 2004; Vernon and LaBonne, 2004; Yang et al., 2004; Lee et al., 2006; Yuen et al., 2007). This evidence concerns the gene TWIST1 and cancer.